End-of-day quote
Taipei Exchange
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
108
TWD
|
-6.09%
|
|
-6.09%
|
-1.82%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,398
|
1,500
|
1,473
|
1,599
|
1,914
|
3,630
|
Enterprise Value (EV)
1 |
349.1
|
523.5
|
397.2
|
501.7
|
939.6
|
2,509
|
P/E ratio
|
13.4
x
|
13.4
x
|
12.8
x
|
13
x
|
14
x
|
17.3
x
|
Yield
|
6.76%
|
6.7%
|
7.13%
|
6.94%
|
4.94%
|
6.14%
|
Capitalization / Revenue
|
1.2
x
|
1.27
x
|
1.46
x
|
1.56
x
|
1.48
x
|
2.28
x
|
EV / Revenue
|
0.3
x
|
0.44
x
|
0.39
x
|
0.49
x
|
0.73
x
|
1.57
x
|
EV / EBITDA
|
2.07
x
|
2.72
x
|
2.16
x
|
2.34
x
|
4.25
x
|
7.1
x
|
EV / FCF
|
2.97
x
|
1.97
x
|
1.9
x
|
2.28
x
|
5.67
x
|
8.96
x
|
FCF Yield
|
33.7%
|
50.8%
|
52.5%
|
43.8%
|
17.6%
|
11.2%
|
Price to Book
|
1.1
x
|
1.17
x
|
1.14
x
|
1.25
x
|
1.38
x
|
2.36
x
|
Nbr of stocks (in thousands)
|
33,000
|
33,000
|
33,000
|
33,000
|
33,000
|
33,000
|
Reference price
2 |
42.36
|
45.45
|
44.64
|
48.45
|
58.00
|
110.0
|
Announcement Date
|
3/27/19
|
3/23/20
|
3/22/21
|
3/24/22
|
3/23/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,165
|
1,178
|
1,009
|
1,028
|
1,292
|
1,594
|
EBITDA
1 |
168.7
|
192.4
|
184.3
|
214.5
|
221
|
353.3
|
EBIT
1 |
133
|
157.8
|
140.8
|
160.4
|
158.3
|
268.6
|
Operating Margin
|
11.42%
|
13.4%
|
13.95%
|
15.6%
|
12.26%
|
16.85%
|
Earnings before Tax (EBT)
1 |
142.4
|
160
|
148.7
|
173.8
|
178.2
|
297.3
|
Net income
1 |
105
|
112.5
|
116
|
123.2
|
137.1
|
210.3
|
Net margin
|
9.01%
|
9.55%
|
11.49%
|
11.98%
|
10.61%
|
13.2%
|
EPS
2 |
3.164
|
3.391
|
3.500
|
3.718
|
4.136
|
6.350
|
Free Cash Flow
1 |
117.6
|
265.7
|
208.6
|
219.9
|
165.7
|
280.1
|
FCF margin
|
10.1%
|
22.55%
|
20.67%
|
21.39%
|
12.83%
|
17.58%
|
FCF Conversion (EBITDA)
|
69.71%
|
138.1%
|
113.24%
|
102.52%
|
74.95%
|
79.29%
|
FCF Conversion (Net income)
|
112.02%
|
236.17%
|
179.87%
|
178.5%
|
120.83%
|
133.2%
|
Dividend per Share
2 |
2.864
|
3.046
|
3.182
|
3.364
|
2.864
|
6.750
|
Announcement Date
|
3/27/19
|
3/23/20
|
3/22/21
|
3/24/22
|
3/23/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,049
|
977
|
1,076
|
1,097
|
974
|
1,121
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
118
|
266
|
209
|
220
|
166
|
280
|
ROE (net income / shareholders' equity)
|
8.6%
|
8.69%
|
7.96%
|
9.65%
|
9.24%
|
14.6%
|
ROA (Net income/ Total Assets)
|
3.84%
|
4.65%
|
4.03%
|
4.51%
|
3.97%
|
5.83%
|
Assets
1 |
2,734
|
2,420
|
2,877
|
2,729
|
3,450
|
3,608
|
Book Value Per Share
2 |
38.50
|
38.80
|
39.10
|
38.90
|
42.10
|
46.50
|
Cash Flow per Share
2 |
26.30
|
20.60
|
23.80
|
24.60
|
20.60
|
28.00
|
Capex
1 |
14.3
|
31.6
|
8.18
|
42.3
|
114
|
70.5
|
Capex / Sales
|
1.22%
|
2.68%
|
0.81%
|
4.11%
|
8.83%
|
4.43%
|
Announcement Date
|
3/27/19
|
3/23/20
|
3/22/21
|
3/24/22
|
3/23/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.82% | 110M | | -0.44% | 1.45B | | -3.32% | 1.43B | | -5.79% | 1.21B | | -14.59% | 899M | | +1.72% | 480M | | +3.85% | 440M | | -48.41% | 369M | | -19.75% | 356M | | -2.93% | 213M |
Medical Equipment Wholesale
|